Original Research ARTICLE
Living at a Geographically Higher Elevation Is Associated with Lower Risk of Metabolic Syndrome: Prospective Analysis of the SUN Cohort
- 1Department of Nutrition, Food Science and Physiology, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain
- 2Centre for Nutrition Research, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain
- 3IDISNA Navarra's Health Research Institute, Pamplona, Spain
- 4CIBERobn Physiopathology of Obesity and Nutrition, Centre of Biomedical Research Network, ISCIII, Madrid, Spain
- 5Department Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain
- 6Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 7Department History, Art History, and Geography, University of Navarra, Pamplona, Spain
Living in a geographically higher altitude affects oxygen availability. The possible connection between environmental factors and the development of metabolic syndrome (MetS) feature is not fully understood, being the available epidemiological evidence still very limited. The aim of the present study was to evaluate the longitudinal association between altitude and incidence of MetS and each of its components in a prospective Spanish cohort, The Seguimiento Universidad de Navarra (SUN) project. Our study included 6860 highly educated subjects (university graduates) free from any MetS criteria at baseline. The altitude of residence was imputed with the postal code of each individual subject residence according to the data of the Spanish National Cartographic Institute and participants were categorized into tertiles. MetS was defined according to the harmonized definition. Cox proportional hazards models were used to assess the association between the altitude of residence and the risk of MetS during follow-up. After a median follow-up period of 10 years, 462 incident cases of MetS were identified. When adjusting for potential confounders, subjects in the highest category of altitude (>456 m) exhibited a significantly lower risk of developing MetS compared to those in the lowest tertile (<122 m) of altitude of residence [Model 2: Hazard ratio = 0.75 (95% Confidence interval: 0.58–0.97); p for trend = 0.029]. Living at geographically higher altitude was associated with a lower risk of developing MetS in the SUN project. Our findings suggest that geographical elevation may be an important factor linked to metabolic diseases.
The metabolic syndrome (MetS) is a cluster of interrelated physiopathological comorbidities identified as a risk factor for cardiovascular disease and type 2 diabetes (Wilson et al., 2005). These factors include obesity (especially central adiposity), hyperglycaemia, dyslipidaemia and hypertension (Grundy et al., 2005). Therefore, this syndrome requires a multiple approach due to its complex and uncertain causes (Grundy et al., 2005; Alberti et al., 2009). The prevalence of MetS is increasing all over the world, closely related to higher obesity and sedentary lifestyle rates (Alberti et al., 2009). Thus the MetS is a public health problem, which could be reduced by means of healthy lifestyle policies and programmes (Lucini et al., 2016).
Despite the fact that some risk factors for developing MetS are widely recognized (e.g., smoking, unhealthy dietary habits, sedentary behavior) (Grundy et al., 2005), insufficient reports about protective factors, such as healthier dietary patterns (Abete et al., 2010), can be found. Concerning modifiable factors, the environment has been suggested to potentially influence the development of metabolic diseases (Friel et al., 2011; Dhurandhar and Keith, 2014; Valdes et al., 2014). Moreover, some studies on subjects living at high altitudes have reported lower incidence rates of conditions linked to MetS such as obesity (Voss et al., 2013; Woolcott et al., 2014; Diaz-Gutierrez et al., 2016), heart disease (Ezzati et al., 2012; Faeh et al., 2016), hypertension (Norboo et al., 2015) or type 2 diabetes (Woolcott et al., 2014).
Previous trials have assessed the role of hypoxia on metabolic and physiologic characteristics (Millet et al., 2016). For instance, body weight was significantly lower in obese subjects exposed to hypobaric hypoxia at geographical altitude (Lippl et al., 2010; Vats et al., 2013). Furthermore, increased basal metabolic rate and leptin levels together with decreased food intake and diastolic blood pressure have been associated with the exposure to higher altitudes (Westerterp-Plantenga et al., 1999; Lippl et al., 2010). The previously mentioned clinical trials suggest that not only normobaric hypoxic exposures, but also hypobaric hypoxia could drive some beneficial effects commonly associated with living at geographical altitude. Some studies have reported beneficial effects of a short-term geographical altitude exposure in subjects with MetS (Schobersberger et al., 2003; Greie et al., 2006; Neumayr et al., 2014; Gutwenger et al., 2015). On the other hand, some investigations have reported non-significant changes in obesity or cardiovascular risk factors in obese individuals treated with sham intermittent hypoxia during exercise (Gonzalez-Muniesa et al., 2015b,c; Gatterer et al., 2015) or without exercise (Querido et al., 2012). Likewise, the effects of exercise recovery in hypobaric hypoxia were analyzed in previous studies, with no statistically significant results (Gatterer et al., 2015). Few studies have observed a reduction in body weight of obese subjects treated with physical exercise under normobaric intermittent hypoxia compared to sham hypoxia group (Netzer et al., 2008; Kong et al., 2014). However, higher oxygen availability has been related with beneficial effects in several clinical disorders with an underlying inflammatory cause (Gonzalez-Muniesa et al., 2015a). However, to our knowledge, no prospective study has analyzed the association between living at different altitudes and the risk of MetS in healthy participants. This analysis hypothesized that living at a geographically higher elevation may protect against metabolic syndrome. Hence, the aim of the present study was to evaluate the longitudinal long-term association between altitude of residence and incidence of MetS in a prospective cohort of Spanish university graduates.
The SUN project (Seguimiento Universidad de Navarra, University of Navarra Follow-up) is a prospective, dynamic, multipurpose cohort study conducted in Spain. The objectives, design and methods of the SUN cohort have been previously described (Martinez-Gonzalez et al., 2002; Martinez-Gonzalez, 2006; Segui-Gomez et al., 2006). Briefly, using biennial mailed questionnaires participants have been continually followed-up. Participants' recruitment started in December, 1999 and it is permanently open. All subjects have obtained a university degree. Up until March, 2012 to have enough time for a 2-year follow-up, the SUN project recruited 21,291 participants. The subjects that ceased to respond the questionnaires of the study (n = 1881) were considered lost to follow-up leaving a total of 19,410 (retention rate = 91%). Participants who had not a minimum follow-up of 6 years were excluded from the study (n = 4205). To avoid reverse causality bias, 3890 individuals who met at least one MetS criterion at baseline were excluded. Pregnant women at baseline and during the follow-up were excluded (n = 2652). In addition, participants suffering from a chronic disease (diabetes, cancer or cardiovascular disease) at baseline were also excluded (n = 625). For the present study, a subsample of the cohort was selected for the final analysis with a total of 6860 participants over 25 years old that had answered the postal code in the baseline questionnaire (Figure 1). The study was conducted according to the guidelines laid down in the Declaration of Helsinki and it was approved by the Human Research Ethical Committee of the University of Navarra. Voluntary completion of the first self-administered questionnaire was considered to imply informed consent.
Figure 1. Flow-chart displaying the participants included in the analyses. N, number of subjects; MetS, Metabolic syndrome; CVD, cardiovascular disease.
Assessment of Habits and Lifestyles
The baseline questionnaire collected subjects' clinical history, daily habits, lifestyle, social characteristics, the time of residence at the current city and self-reported anthropometric information. Leisure-time physical activity was calculated through a baseline 17-item questionnaire. The reproducibility and validity of self-reported physical activity was assessed in a subsample of the cohort (Martinez-Gonzalez et al., 2005). Adherence to the Mediterranean dietary pattern was determined through the score (0–9 points) proposed by Trichopoulou et al. (2003).
Assessment of Altitude
The postal code of each participant's residence and the time they have been living in their city/village was recorded using the baseline questionnaire. We imputed the altitude of each postal code according to Spanish National Cartographic Institute (Ministry of Public Works-Ministerio de Fomento, Spanish Government) using the program GIS ArcGIS v10.3 and categorized participants into tertiles.
Assessment of Metabolic Syndrome
MetS was defined according to the International Diabetes Federation and American Heart Association/National Heart, Lung, and Blood Institute harmonized definition (IDF-AHA/NHLBI) (Alberti et al., 2009). According to it, the MetS diagnosis requires the occurrence of at least three of the following five criteria: central adiposity (according to the country-specific definition waist circumference: ≥94 cm in males and ≥80 cm in females), hypertriglyceridemia (≥150 mg/dL or specific medication), low levels of high-density lipoprotein cholesterol (HDL-c: <40 mg/dL for men and <50 mg/dL for women), elevated blood pressure (BP: systolic ≥130 and/or diastolic ≥85 mmHg or antihypertensive drug treatment in a patient with a history of hypertension), and impaired glucose metabolism (fasting glucose ≥100 mg/dL or drug treatment of elevated glucose).
For a comparison between different MetS diagnosis criteria AHA/NHLBI, IDF and Adult Treatment Panel III (ATP III) MetS definitions were used (Alberti et al., 2009). These requirements differ from those in the harmonized definition in the following terms: AHA/NHLBI defines central adiposity when waist circumference ≥102 cm in males and ≥99 cm in females or when diagnosed of type 2 diabetes; IDF specifies the central adiposity as mandatory criterion and at least two of the four criteria (equal to harmonized definition items); ATP III defines central adiposity as waist circumference ≥102 cm in males and ≥88 cm in females.
Self-reported information about each specific MetS criterion was collected in the Q_6 and Q_8 questionnaires (6th and 8th year follow-up respectively). Additionally, a measuring tape was sent to each participant including an explanation of how to measure their own waist.
Diagnosis of MetS itself, the same as each MetS criterion was previously validated in a subsample of the cohort, finding an agreement between self-reported MetS and MetS diagnosis of at least 90% (Barrio-Lopez et al., 2011).
Estimated tertiles according to their baseline altitude of residence were used to classify the participants included in the study: 0–121 meters (m) as the reference level, 122–456 m and ≥457 m. Baseline characteristics according to their altitude of residence were described using relative frequencies, means and standard deviations.
Cox proportional hazards models were used to assess the association between the tertiles of altitude level and the risk of MetS during follow-up. Person-time of follow-up was calculated for each participant, from the date of completion of the baseline questionnaire until the date of completion of the last follow-up questionnaire, or date of death, whichever occurred first. For the cases of incident MetS, the person-time follow-up was set as the date of the follow-up questionnaire where they met the criteria for MetS diagnosis. The Cox model included age as the underlying time scale for all analyses. All models were stratified by years living in the city/village, categories of participants according to their date of entry into the cohort and categories of age (deciles). An initial model adjusted for gender was calculated. Two multivariable-adjusted models were fitted for potential baseline confounders. Model 1 was adjusted for gender, BMI (Kg/m2), total energy intake (Kcal/d), adherence to Mediterranean dietary pattern (0 to 9 score), physical activity (METs-h/week), sedentary behavior (h/d), hours sitting (h/d), smoking status (non-smoker, smoker, former smoker), snacking between meals (yes/no) and following special diets (yes/no). Model 2 was additionally adjusted for sleeping time (h/d) and alcohol intake (g/d).
Tests for linear trends across increasing categories of altitude were conducted by assigning the median altitude of residence within each category and treating this variable as continuous. The specific relationship between each of the 5 components of the MetS and the altitude levels was assessed. As sensitivity analyses, the risk of developing MetS living at geographically higher altitude was calculated excluding participants with family history of chronic diseases such as obesity, diabetes, stroke and high blood pressure. Hazard Ratios (HR) and their 95% confidence intervals (CI) were calculated. The proportional-hazards assumption was tested with the Schoenfeld residual method and time dependent covariates.
All p-values presented are two-tailed; p < 0.05 was considered statistically significant. Analyses were performed using STATA/SE version 12.0 (StataCorp, College Station, TX, USA).
The main characteristics of participants according to their altitude of residence are shown in Table 1. Higher altitudes on average were associated with younger age, greater proportion of women, lower BMI and less physical activity. No significant differences were found in baseline sedentary behavior, smoking status, alcohol consumption, adherence to the Mediterranean dietary pattern, special diets or sleeping time. Participants in the highest category of altitude had higher energy intake and were more likely to snack between-meals.
Participants were followed-up for a median time of 10 years. During the follow-up period 462 (6.73%) incident cases of MetS were observed (Table 2A). Subjects in the highest category of altitude (>456 m) exhibited a significantly lower risk of developing MetS during follow-up compared to those in the lowest category (<122 m) of altitude of residence [Model 2: HR = 0.75 (95% CI: 0.58–0.97); p for trend = 0.029]. Participants who lived between 123 and 456 m did not show significantly lower risk of developing MetS compared to those in the tertile 1. Moreover a linear trend was observed (p = 0.029 in Model 2). In addition to this, a multivariable linear regression showed that for every additional 100 meters of altitude the MetS incidence (each MetS criteria considered qualitatively on yes or no with a maximum of 5 points) is expected to decrease slightly, but significantly (p-value = 0.003), in the 8-year follow up.
The null hypothesis that the relative hazard was constant over time was confirmed, as a non-significant result was found (p = 0.19). The time-dependent covariates were tested using this method, which gave a non-significant result indicating a non-zero slope, and confirming that the relative hazard is constant over time.
The risk of developing each component of MetS according to the altitude level is shown in Figure 2. The HR and 95% CI for the criteria of MetS were non-statistically significant after adjusting for potential confounders.
Figure 2. Risk of developing each component of MetS according to the altitude level. Multiple adjusted* hazard ratios and 95% CI of incident MetS (harmonized IDF-AHA/NHLBI) according to the altitude of residence. The SUN Project 1999–2012. m, meters; * Adjusted for: gender, BMI, total energy intake, adherence to Mediterranean dietary pattern, physical activity, sedentary behavior, hours sitting, smoking status, snacking between meals, following special diets, sleeping time, and alcohol intake.
Four different definitions of MetS were used to study the hypothesis. These results, illustrated in Table 2B, were all in the same direction showing little variations among them. The reduction in the risk of developing MetS corresponded in all cases to the highest category of altitude compared to the first tertile, ranging from 23% lower odds in the IDF definition to 39% in the AHA/NHLBI definition as the greater effect.
Furthermore, sensitivity analyses were in the same direction as the main results (Figure 3). The risk of developing MetS decreased in the higher altitude level after excluding participants with family background of chronic disease.
Figure 3. Sensitivity analyses excluding subjects with family history of chronic disease. Multiple adjusted* hazard ratios and 95% CI of incident MetS (harmonized IDF-AHA/NHLBI) according to the altitude of residence. The SUN Project 1999–2012. Overall, all the participants included in the main analysis; HBP, high blood pressure; Ref, reference; Alt1, altitude tertile 1; Alt2, altitude tertile 2; Alt3, altitude tertile 3; * Adjusted for: gender, BMI, total energy intake, adherence to Mediterranean dietary pattern, physical activity, sedentary behavior, hours sitting, smoking status, snacking between meals, following special diets, sleeping time, and alcohol intake.
The current study showed that living at geographically higher altitude was significantly associated with a decreased risk of developing MetS in a Spanish population of relatively young university graduates. Moreover this effect followed a linear trend. The Cox model included age as the underlying time scale for all analyses. All models were stratified by years living in the city/village, categories of participants according to their date of entry into the cohort and categories of age (deciles). A model adjusted for gender, and two multivariable models were calculated. The first model with common dietary and lifestyle co-variables and the second model additionally adjusted for other potential confounders.
The higher concentration of oxygen (O2) that can be found in the earth corresponds to sea level (21%). At this altitude level the O2 partial pressure (pO2) is around 160 mmHg. Every 300 m reduces the pO2 1% (McElroy et al., 2000; West, 2002). Our study suggests a potential preventive effect of living at moderately geographical altitude where the participants are exposed to lower pO2, pressure, humidity and temperature. In this sense, the prevalence of obesity has been positively associated with ambient temperature in two different observational studies (Valdes et al., 2014; Yang et al., 2015). It is also possible that other factors such as polymorphisms for high altitude adaptation were involved in this effect (Bigham et al., 2013; Huerta-Sanchez et al., 2013; Valverde et al., 2015). In our study the participants in the higher altitude category were at a median of 591 m and were exposed, for a median time of 20 years, to a standard barometric pressure of 95 kPa, which is 94% of the oxygen available at the sea level. This oxygen pressure translated to the body's oxygen supply taking 14 breaths per minute as the respiratory frequency and a tidal volume of 0.65 liters means an arterial pO2 of 12 kPa, and an oxygen saturation in blood (SaO2) of 97%. By contrast, the median altitude of those who were living in the lowest altitude (43 m) had an atmospheric pO2 of 100 kPa (with almost 100% of oxygen available at sea level). Using the same previous conditions this atmospheric pO2 means an arterial pO2 of 13.2 kPa and a SaO2 of 98% (Cruickshank and Hirschauer, 2004).
This difference of 1.2 kPa is not large, and these calculations have limitations due to the possible adaptive response over years and generations, nonetheless arterial hypoxemia induced by exercise is defined as a reduction in the arterial oxygen pressure only higher than 1 kPa (Nielsen, 2003). This leads to various physiological mechanisms following adaptation due to chronic lower hypoxia. In addition, from a population perspective we have to take into account the potential existence of Rose prevention paradox where factors that make a small difference to the population distribution may be more important than factors that have a clinical impact on a small number of people (Rose et al., 2008).
A significant reduction in the risk of developing MetS associated with living at geographically higher altitudes was found. However, this outcome was only statistically significant for the MetS as a whole but not for each one of its components separately. This lack of significance might be explained by the low incidence of the criteria of MetS in this young cohort (1.3% hypertriglyceridemia, 4.0% low HDL-c, 6.7% hypertension and 2.5% type 2 diabetes). Only central adiposity showed a relatively high incidence in our cohort (27.2%).
The reduction in the risk of developing MetS living at geographical high altitude followed a similar trend to the main analysis in those subjects with no family history of chronic diseases. These results suggest that the genetic background of chronic disease does not interfere with the potential benefits of living at geographical high altitude.
Our results are novel, but they are in line with other studies that did not specifically assessed MetS. Regarding to living at high altitudes, several observational studies have reported lower incidence rates of metabolic diseases in different large cohorts (Ezzati et al., 2012; Voss et al., 2013, 2014; Woolcott et al., 2014; Faeh et al., 2016). Obesity was significantly higher at lower altitude category (<500 m) in an US cross-sectional study after controlling for urbanization, temperature, behavioral and demographic factors (males and females had 5.1 and 3.9 times the odds of obesity, respectively, compared to participants over 3000 m) (Voss et al., 2013). A study about the incidence of overweight/obesity at geographical altitude performed in the SUN cohort found a reduction in the risk of developing overweight or obesity (Diaz-Gutierrez et al., 2016). Lately, a quasi-experimental study carried out with military population observed that individuals with frequent migration stationed at high altitude had 41% lower HR of obesity after multiple adjustment (Voss et al., 2014). Another trial, also performed in a US population, observed a lower risk of developing both obesity and type 2 diabetes (OR: 0.77 and 0.88 respectively) at high altitudes (from 1500 to 3000 m) (Woolcott et al., 2014). In addition, two studies found an inverse association between altitude (more than 1500 m) and mortality from ischemic heart disease, while a positive association was established between altitude and mortality from chronic obstructive pulmonary disease (Ezzati et al., 2012). The mortality rate from coronary heart disease was also reduced in men living above 1220 m (Faeh et al., 2016). These outcomes are consistent with our results, although they enrolled participants living at considerably higher altitudes than those in our cohort (up to 3500 m vs. <2000 m in our study). Higher hypertension prevalence was associated to highest altitudes (more than 2000 m) in highlanders of India (Norboo et al., 2015), which is opposed to our results concerning hypertension, possibly because their study was carried out with very high altitudes. As previously discussed, to date there are no longitudinal studies analyzing the association between living at geographical high altitude and the incidence of MetS.
Notwithstanding that metabolic syndrome definition is controversial (Balarini and Braga, 2016), we have considered the most widely accepted definitions of this concept to test our hypothesis. Comparisons conducted with different definitions of MetS showed similar results to the main analysis. However, diagnosis criteria influenced the association of altitude living and the risk of developing MetS, being AHA/NHLBI definition the most modified. This finding could be explained due to the central adiposity criterion, included in the AHA/NHLBI criteria, as high waist circumference (≥102 cm in males and ≥88 cm in females) or diagnosed type 2 diabetes (under drug treatment). AHA/NHLBI and ATP III share the cut-off point of waist circumference, as they do with the reduction in the risk of developing MetS (AHA/NHLBI 39% and ATP III 34% less odds). On the contrary, the other definitions (IDF and harmonized IDF-AHA/NHLBI) share the limit waist circumference (waist circumference: ≥94 cm in males and ≥80 cm in females) and their results were similar (Harmonized 25% and IDF 23% less odds).
Some limitations should be noted. Participants' high educational level increases the internal validity of the results, even though it could make our study population less representative. This feature might influence on their willing to participate in epidemiologic cohorts as they usually are healthier than the general population (Alonso et al., 2006). We should be cautious to generalize the results to the general population. A different sample may produce different results and therefore, it could be interesting to test our hypothesis in a different sample with participants other than graduates. However, several potential confounding factors related to lifestyle were used for adjustments. Another potential limitation is the way of collecting data relative to altitude, as it was only measured at baseline assuming that the participants remained at the same altitude over the follow-up period. Moving to a different altitude might be a limitation in our study, since some participants may have changed their permanent residence. Moreover, the exposure variable has a limiting factor in this study since in Spain there are few people living over 1500 meters. Atmospheric characteristics (temperature, humidity or pressure) and population density-related features (pollution from urban areas, migrations or food accessibility) were not available in our study, but they could be involved in the effects of living at geographical high altitudes. These data would help to clarify the role of environmental factors in the development of chronic diseases; nonetheless urban areas are more or less well distributed due to the presence of big cities both in the lower and in the other two tertiles of altitude. Finally, some clinical parameters could have helped to avoid potential confounders as self-reporting could lead to bias. Nevertheless, participants were not aware of the objective of the study when they answered the questionnaires of the project. Finally, although we have adjusted for potential confounders, we cannot rule out the existence of residual confounding.
Major advantages are its prospective design with at least 6 years of follow-up to avoid reverse causation bias, the previously validated methods to assess the main variables (Barrio-Lopez et al., 2011), the use of a large sample of participants and their university education, which helped them to provide a high quality of information in their answers to the questionnaires and also adds homogeneity to the cohort regarding socio-demographic factors. These features of the SUN cohort may reduce the potential for confounding.
In this study of a Spanish population composed of university graduates, we found that to live at geographically higher altitude was directly associated with a lower risk of developing MetS after 6 and 8 years of follow-up. This association was only significant when MetS was analyzed as a whole. However, this is a preliminary result and future studies with longer follow-up periods, larger sample size and higher altitudes are needed. Additional research, even including the future (but remote) possibility of conducting a randomized preventive intervention, should clarify the mechanisms of this relationship, and assess the pros and cons of geographical high altitude residency on MetS prevention. Moreover, our results need further validation in the general population. Up to date, this is apparently the first large longitudinal study analyzing the association between MetS and altitude. Our findings suggest that geographical elevation may be an important factor linked to metabolic diseases.
Conceived and designed the study: AL, PG, AM. Managed the data set including data preparation, performed data analyses and assisted with interpretation of the study findings: AL, MB, CS, AP, JD, JP, MM, PG, AM. Analyzed the data: AL, AP, MB, MM, PG, AM. Contributed to writing and revising the manuscript: AL, MB, CS, AP, JD, JP, MM, PG, AM. All authors read and approved the final manuscript.
The SUN Project has received funding from the Spanish Government Carlos III Health Institute Centre of Biomedical Research Network: CIBERobn Physiopathology of Obesity and Nutrition, and the European Regional Development Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, and G03/140), the Navarra Regional Government (45/2011, 122/2014), and the University of Navarra.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
We would like to thank all participants of the SUN project for their continued cooperation and participation. AL is fully acknowledged for the fellowships to Asociación de Amigos de la Universidad de Navarra (ADA) and the FPU from the Spanish Ministry of Education, Culture and Sport (MECD).
Abete, I., Astrup, A., Martinez, J. A., Thorsdottir, I., and Zulet, M. A. (2010). Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr. Rev. 68, 214–231. doi: 10.1111/j.1753-4887.2010.00280.x
Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., et al. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644
Alonso, A., Segui-Gomez, M., de Irala, J., Sanchez-Villegas, A., Beunza, J. J., and Martinez-Gonzalez, M. A. (2006). Predictors of follow-up and assessment of selection bias from dropouts using inverse probability weighting in a cohort of university graduates. Eur. J. Epidemiol. 21, 351–358. doi: 10.1007/s10654-006-9008-y
Balarini, C. M., and Braga, V. A. (2016). Editorial: new translational insights on metabolic syndrome: obesity, hypertension, diabetes and beyond. Front. Physiol. 7:229. doi: 10.3389/978-2-88919-924-2
Barrio-Lopez, M. T., Bes-Rastrollo, M., Beunza, J. J., Fernandez-Montero, A., Garcia-Lopez, M., and Martinez-Gonzalez, M. A. (2011). Validation of metabolic syndrome using medical records in the SUN cohort. BMC Public Health 11:867. doi: 10.1186/1471-2458-11-867
Bigham, A. W., Wilson, M. J., Julian, C. G., Kiyamu, M., Vargas, E., Leon-Velarde, F., et al. (2013). Andean and Tibetan patterns of adaptation to high altitude. Am. J. Hum. Biol. 25, 190–197. doi: 10.1002/ajhb.22358
Diaz-Gutierrez, J., Martinez-Gonzalez, M. A., Pons Izquierdo, J. J., Gonzalez-Muniesa, P., Martinez, J. A., and Bes-Rastrollo, M. (2016). Living at higher altitude and incidence of overweight/obesity: prospective analysis of the SUN Cohort. PLoS ONE 11:e0164483. doi: 10.1371/journal.pone.0164483
Ezzati, M., Horwitz, M. E., Thomas, D. S., Friedman, A. B., Roach, R., Clark, T., et al. (2012). Altitude, life expectancy and mortality from ischaemic heart disease, stroke, COPD and cancers: national population-based analysis of US counties. J. Epidemiol. Commun. Health 66:e17. doi: 10.1136/jech.2010.112938
Faeh, D., Moser, A., Panczak, R., Bopp, M., Roosli, M., Spoerri, A., et al. (2016). Independent at heart: persistent association of altitude with ischaemic heart disease mortality after consideration of climate, topography and built environment. J. Epidemiol. Commun. Health 70, 798–806. doi: 10.1136/jech-2015-206210
Friel, S., Bowen, K., Campbell-Lendrum, D., Frumkin, H., McMichael, A. J., and Rasanathan, K. (2011). Climate change, noncommunicable diseases, and development: the relationships and common policy opportunities. Annu. Rev. Public Health 32, 133–147. doi: 10.1146/annurev-publhealth-071910-140612
Gatterer, H., Haacke, S., Burtscher, M., Faulhaber, M., Melmer, A., Ebenbichler, C., et al. (2015). Normobaric intermittent hypoxia over 8 months does not reduce body weight and metabolic risk factors - a randomized, single blind, placebo-controlled study in normobaric hypoxia and normobaric sham hypoxia. Obes. Facts 8, 200–209. doi: 10.1159/000431157
Gonzalez-Muniesa, P., Garcia-Gerique, L., Quintero, P., Arriaza, S., Lopez-Pascual, A., and Martinez, J. A. (2015a). Effects of hyperoxia on oxygen-related inflammation with a focus on obesity. Oxid. Med. Cell. Longev. 2015:8957827. doi: 10.1155/2016/8957827
Gonzalez-Muniesa, P., Lopez-Pascual, A., de Andres, J., Lasa, A., Portillo, M. P., Aros, F., et al. (2015b). Impact of intermittent hypoxia and exercise on blood pressure and metabolic features from obese subjects suffering sleep apnea-hypopnea syndrome. J. Physiol. Biochem. 71, 589–599. doi: 10.1007/s13105-015-0410-3
Gonzalez-Muniesa, P., Quintero, P., De Andres, J., and Martinez, J. A. (2015c). Hypoxia: a consequence of obesity and also a tool to treat excessive weight loss. Sleep Breath. 19, 7–8. doi: 10.1007/s11325-014-0972-2
Greie, S., Humpeler, E., Gunga, H. C., Koralewski, E., Klingler, A., Mittermayr, M., et al. (2006). Improvement of metabolic syndrome markers through altitude specific hiking vacations. J. Endocrinol. Invest. 29, 497–504. doi: 10.1007/BF03344138
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., et al. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit. Pathw. Cardiol. 4, 198–203. doi: 10.1097/00132577-200512000-00018
Gutwenger, I., Hofer, G., Gutwenger, A. K., Sandri, M., and Wiedermann, C. J. (2015). Pilot study on the effects of a 2-week hiking vacation at moderate versus low altitude on plasma parameters of carbohydrate and lipid metabolism in patients with metabolic syndrome. BMC Res. Notes 8:103. doi: 10.1186/s13104-015-1066-3
Huerta-Sanchez, E., Degiorgio, M., Pagani, L., Tarekegn, A., Ekong, R., Antao, T., et al. (2013). Genetic signatures reveal high-altitude adaptation in a set of ethiopian populations. Mol. Biol. Evol. 30, 1877–1888. doi: 10.1093/molbev/mst089
Kong, Z., Zang, Y., and Hu, Y. (2014). Normobaric hypoxia training causes more weight loss than normoxia training after a 4-week residential camp for obese young adults. Sleep Breath. 18, 591–597. doi: 10.1007/s11325-013-0922-4
Lippl, F. J., Neubauer, S., Schipfer, S., Lichter, N., Tufman, A., Otto, B., et al. (2010). Hypobaric hypoxia causes body weight reduction in obese subjects. Obesity (Silver. Spring). 18, 675–681. doi: 10.1038/oby.2009.509
Lucini, D., Zanuso, S., Solaro, N., Vigo, C., Malacarne, M., and Pagani, M. (2016). Reducing the risk of metabolic syndrome at the worksite: preliminary experience with an ecological approach. Acta Diabetol. 53, 63–71. doi: 10.1007/s00592-015-0744-x
Martinez-Gonzalez, M. A., Lopez-Fontana, C., Varo, J. J., Sanchez-Villegas, A., and Martinez, J. A. (2005). Validation of the Spanish version of the physical activity questionnaire used in the Nurses' Health Study and the Health Professionals' Follow-up Study. Public Health Nutr. 8, 920–927. doi: 10.1079/PHN2005745
Martinez-Gonzalez, M. A., Sanchez-Villegas, A., De Irala, J., Marti, A., and Martinez, J. A. (2002). Mediterranean diet and stroke: objectives and design of the SUN project. Seguimiento Universidad de Navarra. Nutr. Neurosci. 5, 65–73 doi: 10.1080/10284150290007047
McElroy, M. K., Gerard, A., Powell, F. L., Prisk, G. K., Sentse, N., Holverda, S., et al. (2000). Nocturnal O2 enrichment of room air at high altitude increases daytime O2 saturation without changing control of ventilation. High Alt. Med. Biol. 1, 197–206. doi: 10.1089/15270290050144190
Millet, G. P., Debevec, T., Brocherie, F., Malatesta, D., and Girard, O. (2016). Therapeutic use of exercising in hypoxia: promises and limitations. Front. Physiol. 7:224. doi: 10.3389/fphys.2016.00224
Netzer, N. C., Chytra, R., and Kupper, T. (2008). Low intense physical exercise in normobaric hypoxia leads to more weight loss in obese people than low intense physical exercise in normobaric sham hypoxia. Sleep Breath. 12, 129–134. doi: 10.1007/s11325-007-0149-3
Neumayr, G., Fries, D., Mittermayer, M., Humpeler, E., Klingler, A., Schobersberger, W., et al. (2014). Effects of hiking at moderate and low altitude on cardiovascular parameters in male patients with metabolic syndrome: Austrian Moderate Altitude Study. Wilderness Environ. Med. 25, 329–334. doi: 10.1016/j.wem.2014.01.003
Norboo, T., Stobdan, T., Tsering, N., Angchuk, N., Tsering, P., Ahmed, I., et al. (2015). Prevalence of hypertension at high altitude: cross-sectional survey in Ladakh, Northern India 2007-2011. BMJ Open 5:e007026. doi: 10.1136/bmjopen-2014-007026
Querido, J. S., Sheel, A. W., Cheema, R., Van Eeden, S., Mulgrew, A. T., and Ayas, N. T. (2012). Effects of 10 days of modest intermittent hypoxia on circulating measures of inflammation in healthy humans. Sleep Breath. 16, 657–662. doi: 10.1007/s11325-011-0555-4
Schobersberger, W., Schmid, P., Lechleitner, M., von Duvillard, S. P., Hortnagl, H., Gunga, H. C., et al. (2003). Austrian Moderate Altitude Study 2000 (AMAS 2000). The effects of moderate altitude (1,700 m) on cardiovascular and metabolic variables in patients with metabolic syndrome. Eur. J. Appl. Physiol. 88, 506–514. doi: 10.1007/s00421-002-0736-8
Segui-Gomez, M., de la Fuente, C., Vazquez, Z., de Irala, J., and Martinez-Gonzalez, M. A. (2006). Cohort profile: the 'seguimiento Universidad de Navarra' (SUN) study. Int. J. Epidemiol. 35, 1417–1422. doi: 10.1093/ije/dyl223
Trichopoulou, A., Costacou, T., Bamia, C., and Trichopoulos, D. (2003). Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 348, 2599–2608. doi: 10.1056/NEJMoa025039
Valdes, S., Maldonado-Araque, C., Garcia-Torres, F., Goday, A., Bosch-Comas, A., Bordiu, E., et al. (2014). Ambient temperature and prevalence of obesity in the Spanish population: the Di@bet.es study. Obesity (Silver. Spring) 22, 2328–2332. doi: 10.1002/oby.20866
Valverde, G., Zhou, H., Lippold, S., de Filippo, C., Tang, K., Lopez Herraez, D., et al. (2015). A novel candidate region for genetic adaptation to high altitude in Andean populations. PLoS ONE 10:e0125444. doi: 10.1371/journal.pone.0125444
Vats, P., Ray, K., Majumadar, D., Amitabh, Joseph, D. A., Bayen, S., et al. (2013). Changes in cardiovascular functions, lipid profile, and body composition at high altitude in two different ethnic groups. High Alt. Med. Biol. 14, 45–52. doi: 10.1089/ham.2012.1071
Voss, J. D., Allison, D. B., Webber, B. J., Otto, J. L., and Clark, L. L. (2014). Lower obesity rate during residence at high altitude among a military population with frequent migration: a quasi-experimental model for investigating spatial causation. PLoS ONE 9:e93493. doi: 10.1371/journal.pone.0093493
Voss, J. D., Masuoka, P., Webber, B. J., Scher, A. I., and Atkinson, R. L. (2013). Association of elevation, urbanization and ambient temperature with obesity prevalence in the United States. Int. J. Obes. 37, 1407–1412. doi: 10.1038/ijo.2013.5
Westerterp-Plantenga, M. S., Westerterp, K. R., Rubbens, M., Verwegen, C. R., Richelet, J. P., and Gardette, B. (1999). Appetite at “high altitude” [Operation Everest III (Comex-'97)]: a simulated ascent of Mount Everest. J. Appl. Physiol. (1985) 87, 391–399.
Wilson, P. W., D'Agostino, R. B., Parise, H., Sullivan, L., and Meigs, J. B. (2005). Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112, 3066–3072. doi: 10.1161/CIRCULATIONAHA.105.539528
Woolcott, O. O., Castillo, O. A., Gutierrez, C., Elashoff, R. M., Stefanovski, D., and Bergman, R. N. (2014). Inverse association between diabetes and altitude: a cross-sectional study in the adult population of the United States. Obesity (Silver. Spring). 22, 2080–2090. doi: 10.1002/oby.20800
Keywords: environmental health, metabolic syndrome, cohort studies, preventive medicine, morbidity
Citation: Lopez-Pascual A, Bes-Rastrollo M, Sayón-Orea C, Perez-Cornago A, Díaz-Gutiérrez J, Pons JJ, Martínez-González MA, González-Muniesa P and Martínez JA (2017) Living at a Geographically Higher Elevation Is Associated with Lower Risk of Metabolic Syndrome: Prospective Analysis of the SUN Cohort. Front. Physiol. 7:658. doi: 10.3389/fphys.2016.00658
Received: 07 October 2016; Accepted: 14 December 2016;
Published: 04 January 2017.
Edited by:Tadej Debevec, Jožef Stefan Institute, Slovenia
Reviewed by:Martin Faulhaber, University of Innsbruck, Austria
Takuma Morishima, University of Tsukuba, Japan
Copyright © 2017 Lopez-Pascual, Bes-Rastrollo, Sayón-Orea, Perez-Cornago, Díaz-Gutiérrez, Pons, Martínez-González, González-Muniesa and Martínez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pedro González-Muniesa, email@example.com
†These authors have contributed equally to this work.